Mesenchymal stem cells
MSC-cGVHD-2020
Phase 2 mab active
Quick answer
Mesenchymal stem cells for Chronic Graft-versus-host Disease is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Chronic Graft-versus-host Disease
- Phase
- Phase 2
- Modality
- mab
- Status
- active